SeekingAlpha · Jun 14, 2026
IHI: Pressured Consumers, Unclear Healthcare Policy, Weak Price Action
Hold iShares US Medical Devices ETF (IHI) after a 20% YTD drop: fair valuation but bearish technicals, concentration risks and low yieldâread now.
IH
AMEX · IHI
iShares U.S. Medical Devices ETF
Financial Services · Asset Management
$56.64
Up+$1.20 (+2.16%)
Updated Aug 20, 2026, 8:27 AM
SID Score
5.2/10
Composite research score
Smart Money
54/100
Neutral
- Market cap
- 4.35B
- P/E ratio
- —
- Dividend yield
- 0.45%
- 52-week range
- $47.37 – $57.44
- Volume
- 2.49M
- Avg. volume
- 1.22M
Price performance
IHI price history
1M range · 21 trading sessions · Daily adjusted prices
IHI closed at $56.64 after 21 trading sessions, up 14.63% for the selected period.
- Last close
- $56.64
- Period change
- +14.63%
- Period low
- $49.41
- Period high
- $56.64
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 19, 2026 | $55.79 | $57.17 | $55.655 | $56.64 | 2.49M |
| Aug 18, 2026 | $55.57 | $56.24 | $55.42 | $55.44 | 2.23M |
| Aug 17, 2026 | $55.32 | $55.66 | $54.975 | $55.08 | 2.01M |
| Aug 14, 2026 | $56.15 | $56.20 | $55.695 | $55.76 | 2.62M |
| Aug 13, 2026 | $56.31 | $56.47 | $55.76 | $56.11 | 1.92M |
| Aug 12, 2026 | $55.56 | $56.18 | $55.055 | $56.08 | 2.64M |
| Aug 11, 2026 | $55.37 | $56.105 | $55.30 | $55.98 | 2.32M |
| Aug 10, 2026 | $54.28 | $55.48 | $54.175 | $55.45 | 3.17M |
| Aug 7, 2026 | $53.73 | $54.395 | $53.42 | $54.38 | 3.34M |
| Aug 6, 2026 | $54.07 | $54.38 | $53.571 | $54.11 | 1.92M |
| Aug 5, 2026 | $54.19 | $54.20 | $53.17 | $53.72 | 2.81M |
| Aug 4, 2026 | $53.98 | $54.155 | $53.665 | $54.11 | 2.41M |
| Aug 3, 2026 | $53.29 | $54.32 | $53.27 | $54.21 | 3.3M |
| Jul 31, 2026 | $52.20 | $52.675 | $51.66 | $52.51 | 2.84M |
| Jul 30, 2026 | $52.93 | $53.23 | $52.195 | $52.74 | 2.75M |
| Jul 29, 2026 | $52.49 | $53.60 | $52.43 | $53.30 | 2.65M |
| Jul 28, 2026 | $52.18 | $53.395 | $52.145 | $52.69 | 4.15M |
| Jul 27, 2026 | $50.62 | $51.73 | $50.62 | $51.37 | 2.52M |
| Jul 24, 2026 | $49.93 | $50.635 | $49.845 | $50.23 | 2.78M |
| Jul 23, 2026 | $49.36 | $49.65 | $49.06 | $49.44 | 2.42M |
| Jul 22, 2026 | $50.22 | $50.28 | $49.33 | $49.41 | 2M |
Latest IHI news
The latest Smart Investors Daily articles mentioning IHI.
Stock researchCompany · Overview
IHI research
Overview
Company profile and research snapshot.
Company profile
The fund will invest at least 80% of its assets in the component securities of the index and in investments that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the index, but which BFA believes will help the fund track the index. The fund is non-diversified.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
SeekingAlpha · Mar 4, 2026
DexCom: Gaining Favor, With Useful Tailwinds To Support It Even Further
Dexcom (DXCM) outlook: CGM leader with improving margins, $1B+ free cash flow and attractive risk-reward vs peers.
Yahoo · Feb 23, 2026
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
Sector ETF report for IHI
defenseworld.net · Dec 10, 2025
Flow Traders U.S. LLC Sells 20,969 Shares of iShares U.S. Medical Devices ETF $IHI
Flow Traders U.S. LLC decreased its holdings in shares of iShares U.S. Medical Devices ETF (NYSEARCA:IHI) by 60.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,736 shares of the company's stock after selling 20,969 shares during the period.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
